Are Peptides coming off of the FDA Category 2 list? A legal breakdown. When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # FDA mulls compounding for peptides previously flagged over safety risks BioSpace FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea